Alternatively, it has been proposed that the abnormal growth rate of T-cells in association with IL-2 deficiency may be due to tolerogenic properties of IL-2, mediated through interactions with regulatory T-cells (Treg)[69], [70], [71]. The gene discussed is IL2; the disease is hyperinsulinemic hypoglycemia, familial, 4.